Kantar Health Blog

  • Neesha Suvarna
    The role of PD-1 in suppression of antitumor immunity was one of the hottest topics at the 2012 American Society of Clinical Oncology (ASCO) annual meeting. Excitement around this topic intensified at ASCO 2013, and the story continues to unfold in 2014.
    Continue Reading > | Go comment! | Share
  • Neesha Suvarna
    To date, the field of myeloma therapy has been dominated by proteasome inhibitors and immunomodulators (IMiDs). The future of myeloma seems promising, with multiple novel targeted therapies that are currently in development; one of these reported data at ASCO 2014.
    Continue Reading > | Go comment! | Share
  • Stephanie Hawthorne
    In epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NCSLC), tyrosine kinase inhibitors (TKIs) such as Tarceva® (erlotinib, Genentech/Roche/Astellas) are the standard of care for first-line metastatic patients in the United States and Europe/Japan, respectively.
    Continue Reading > | Go comment! | Share
  • Neesha Suvarna
    Oncology Conference Insight: AACR - Final progression-free survival (PFS) data from the PALOMA-1 phase II trial was presented at the Plenary Session of the 2014 American Association for Cancer Research (AACR; Finn, abstract CT-101). Observers were expecting positive news, since interim analyses already had shown PFS benefit for palbociclib (PD 0332991, Pfizer/Amgen/Onyx) and Pfizer had indicated via press release that the final PFS results were positive (February 3, 2014).
    Continue Reading > | Go comment! | Share
  • Stephanie Hawthorne
    Oncology Conference Insight: ASCO GU --- Prostate cancer is the most common cancer in men and the second most common cause of cancer deaths in men in the United States. The incident population of prostate cancer in the United States was above 200,000 patients in 2013. The rate of prostate cancer growth varies from very slow to moderately rapid, and some patients may have prolonged survival even after the cancer has metastasized to distant sites such as bone.
    Continue Reading > | Go comment! | Share